Eli Lilly and Company, which manufactures one of the new weight-loss drugs, has launched an advertising campaign reinforcing that the drugs should not be used for cosmetic weight loss.
Antiquated laws requiring oncologists and other doctors offering telehealth to have medical licenses in multiple states unnecessarily restrict patient access, a New Jersey lawsuit claimed.